|
| Exchange Disseminated Time | Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2015, inter alia, has approved the following:
1. Formulated and adopted "Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information" (Code of Fair Disclosure) of the Company (under Regulation 8 of SEBI (Prohibition of Insider Trading) Regulations, 2015).
2. Formulated and approved "Code of Conduct for Prohibition of Insider Trading" (Code of Conduct) of the Company (under Regulation 9 of SEBI (Prohibition of Insider Trading) Regulations, 2015).
Further, the Nomination & Remuneration Committee, at its meeting held on May 27, 2015, approved the reappointment of Dr. Dinesh S. Patel as CEO & Managing Director as well as Dr. Sachin D Patel as Deputy Managing Director for a period of five years effective from June 29, 2015, subject to approval of the Members. The Board also approved the said proposals. |
|
|